Abstract
Cancer morbidity decreased in the last few years of the twentieth century, in large part due to early detection as well as the campaign against tobacco. The relationship between viruses and cancer, and the elaboration of the oncogene theory—from the early work on phage lambda and lysogeny—to oncogenes is presented. The majority of cancers result from somatic mutations and chromosomal rearrangements, which may cause proto-oncogene activation. Mutations in tumor suppressor genes also end in tumor formation. The function of these different genes is discussed, as are hereditary cancers. Viruses—such as papilloma, hepatitis C, hepatitis B, human herpes 8, Epstein-Barr virus and HTLV-1—induce cancers by varied mechanisms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Knudson, A. G, Jr. (1974). Heredity and human cancer. American Journal of Pathology, 77(1), 77–84.
Duesberg, P. (2007). Chromosomal chaos and cancer. Scientific American, 296(5), 52–59.
Harris, H. (2008). Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. Preface. Journal of Cell Science, 121 Suppl 1, v–vi.
Nakajima, H., Takaishi, M., Yamamoto, M., Kamijima, R., Kodama, H., Tarutani, M., et al. (2009). Screening of the specific polyoma virus as diagnostic and prognostic tools for Merkel cell carcinoma. Journal of Dermatological Science, 56(3), 211–213.
Todaro, G. J., & Huebner, R. J. (1972). N.A.S. symposium: New evidence as the basis for increased efforts in cancer research. Proceedings of the National Academy of Sciences of the United States of America, 69(4), 1009–1015.
Gross, L. (1974). Facts and theories on viruses causing cancer and leukemia. Proceedings of the National Academy of Sciences of the United States of America, 71(5), 2013–2017.
Huebner, R. J., & Todaro, G. J. (1969). Oncogenes of RNA tumor viruses as determinants of cancer. Proceedings of the National Academy of Sciences of the United States of America, 64(3), 1087–1094.
Rho, H. M., Poiesz, B., Ruscetti, F. W., & Gallo, R. C. (1981). Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line. Virology, 112(1), 355–360.
Temin, H. M., & Mizutani, S. (1970). RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature, 226(5252), 1211–1213.
Panet, A., Baltimore, D., & Hanafusa, T. (1975). Quantitation of avian RNA tumor virus reverse transcriptase by radioimmunoassay. Journal of Virology, 16(1), 146–152.
Murray, M. J., Shilo, B. Z., Shih, C., Cowing, D., Hsu, H. W., & Weinberg, R. A. (1981). Three different human tumor cell lines contain different oncogenes. Cell, 25(2), 355–361.
Easton, D. F. (1999). How many more breast cancer predisposition genes are there? Breast cancer research: BCR, 1(1), 14–17.
Campeau, P. M., Foulkes, W. D., & Tischkowitz, M. D. (2008). Hereditary breast cancer: new genetic developments, new therapeutic avenues. Human Genetics, 124(1), 31–42.
Pal, T., Permuth-Wey, J., Betts, J. A., Krischer, J. P., Fiorica, J., Arango, H., et al. (2005). BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer, 104(12), 2807–2816.
Lancaster, J. M., Carney, M. E., & Futreal, P. A. (1997). BRCA 1 and 2–A Genetic Link to Familial Breast and Ovarian Cancer. Medscape Womens Health, 2(2), 7.
Robson, M., Dabney, M. K., Rosenthal, G., Ludwig, S., Seltzer, M. H., Gilewski, T., et al. (1997). Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. Genet Test, 1(1), 47–51.
Burkitt, D. P. (1983). The discovery of Burkitt’s lymphoma. Cancer, 51(10), 1777–1786.
Gessain, A., Sudaka, A., Briere, J., Fouchard, N., Nicola, M. A., Rio, B., et al. (1996). Kaposi sarcoma-associated herpes-like virus (human herpes virus type 8) DNA sequences in multicentric Castleman’s disease: Is there any relevant association in non-human immunodeficiency virus-infected patients? Blood, 87(1), 414–416.
O’Neill, E., Henson, T. H., Ghorbani, A. J., Land, M. A., Webber, B. L., & Garcia, J. V. (1996). Herpes virus-like sequences are specifically found in Kaposi sarcoma lesions. Journal of Clinical Pathology, 49(4), 306–308.
Conjeevaram, H. S., Fried, M. W., Jeffers, L. J., Terrault, N. A., Wiley-Lucas, T. E., Afdhal, N., et al. (2006). Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology, 131(2), 470–477.
Howell, C. D., Dowling, T. C., Paul, M., Wahed, A. S., Terrault, N. A., Taylor, M., et al. (2008). Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association, 6(5), 575–583.
Abe, H., Hayes, C. N., Ochi, H., Maekawa, T., Tsuge, M., Miki, D., et al. (2011). IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy. Journal of Hepatology, 54(6), 1094–1101.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Taylor, M.W. (2014). Cancer and Viruses. In: Viruses and Man: A History of Interactions. Springer, Cham. https://doi.org/10.1007/978-3-319-07758-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-07758-1_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07757-4
Online ISBN: 978-3-319-07758-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)